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ABSTRACT
The aim of this systematic review was to identify and appraise studies which tracked changes in the sensation of breathlessness,
as described in terms of intensity, unpleasantness, its effect on impairment levels or quality of life, over two or more years in
people with COPD. Four major databases were searched. Twelve studies were included for full analysis. These studies were a
mix of observational and experimental in their design, and were found to have high methodological quality. Subjects in the
studies were, overall, severely impaired at the start of the two year period, according to level of airflow restriction. Impairment
levels did not change dramatically over the two year period (mean decrease of 2%). Thirteen outcome measures were identified
within the studies. Modest improvements over the two year period were noted using tools which measure breathlessness
intensity and self-reported impairment levels when forms of management were implemented. No clear conclusions could be
drawn about changes in quality of life over two years for people with COPD. No studies have reported changes in the quality of
the sensation of breathlessness over a minimum two-year period. There is a distinct lack of longitudinal studies tracking changes
in the qualitative sensations of breathlessness.
INTRODUCTION
The last two decades have seen a new wave of research into the sensation of breathlessness. What was previously thought of
as a generic sensation commonly experienced by people with respiratory, cardiac, and neuromuscular conditions is now
accepted to be as complex and multidimensional as pain. Breathlessness is commonly experienced by people with chronic
obstructive pulmonary disease (COPD), and longitudinal studies into the disease frequently use a variety of verified
measurement tools to track changes in the intensity or severity of subjects’ breathlessness, their degree of airflow obstruction,
and their exercise capacity.1-3 Yet it is only relatively recently that the research and clinical fields have begun to see the benefits
of exploring not only the intensity, but also the quality of the sensation of breathlessness.
Contemporary neural imaging studies confirm that different neuronal pathways are responsible for the processing of affective
(unpleasantness) and sensory (intensity) domains of dyspnoea, and consequently, future studies exploring dyspnoea have been
encouraged to use separate visual analogue scales for both unpleasantness and intensity of dyspnoea.4-7 The McGill Pain
Questionnaire requires people to select words from a number of domains in order to describe the qualitative sensations of their
pain experience. In a similar way, researchers working in the area of breathlessness / dyspnoea have considered the language
that people use to describe this sensation as a means of identifying and exploring the qualitative affective domain rather than
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simply the intensity of breathlessness. The language used by people to describe the sensation of breathlessness has been
shown to reflect underlying pathobiological mechanisms causing the sensation.8 People with COPD can be distinguished from
people without the disease through a unique gathering of words and phrases describing the sensation.9 This evidence would
suggest that there is a place for tools which also measure the quality of the sensation, and these tools could then be used
longitudinally to track changes in the sensation over a period of time.
Breathlessness is the most common symptom of COPD. In general, epidemiological studies investigating morbidity/mortality for
COPD consider changes over three to five years and give priority to physiological outcomes such as pulmonary function
parameters and body mass index as predictors for life expectancy. While epidemiological studies of people with COPD
commonly report either the presence or intensity of this symptom, it is unclear to what extent the qualitative domain has been
explored and whether changes in this symptom are evident within shorter timeframes. A systematic search of the literature was
undertaken to identify studies which reported longitudinal changes in the sensation of breathlessness for people with chronic
obstructive pulmonary disease (COPD). The aim was to identify which assessment tools have been used to monitor the
sensation of breathlessness (intensity, unpleasantness, or impact upon daily life), and whether the sensation of breathlessness
changed over two years in people with COPD.
Using the PICO framework, a specific question was formulated for the systematic search. The population (P) of interest was
people with COPD. The aim was to assess changes in the sensation of breathlessness over time with natural progression of the
disease. The effect of interventions (I) for COPD management was not a specific focus of the review. Studies which included
trials of medication or intervention such as pulmonary rehabilitation were included, as these forms of treatment could be
considered “usual care” for people with COPD. However, studies in which the sole intervention was surgical (such as lung
volume reduction or lung transplant surgery) were excluded, as these interventions were likely to alter the normal course of the
disease and subsequent changes in breathlessness. No comparison (C) group was sought. The outcome measures (O) from
which data was extracted were tools which reported intensity, quality or daily impact of breathlessness. These had to be
measured on at least two occasions, two years apart from each other.
METHODOLOGY
Two basic groups of search terms were employed in the search. The first group concerned the identifying feature of the target
population; a diagnosis of COPD. The second group of terms aimed to identify study designs which were likely to report data
over the course of at least two years on a variety of respiratory related outcomes including the sensation of breathlessness. In
order to ascertain as broad a scope of each term as possible, the MeSH database was accessed and used through PubMed,
and Boolean commands were included where possible. A final list of the terms selected for searching is shown in Table 1.
TABLE 1: Search terms for systematic review of the literature
Group 1 (COPD)
·
·
·
·
·
·
·

Chronic Obstructive Airway* Disease
Chronic Obstructive Lung Disease
Chronic Obstructive Pulmonary Disease
COAD
COPD
Chronic Airflow Obstruction*
Obstructive Lung Disease*
“OR” in between each term

Group 2 (change over time)
·
·
·
·
·
·
·
·
·
·
·
·
·

Longitudinal Stud*
Longitudinal Survey*
Follow-Up Stud*
Follow Up Stud*
Follow-Up Survey*
Follow Up Survey*
Followup Stud*
Followup Survey*
Prospective Stud*
Cohort Stud*
Concurrent Stud*
RCT
Intervention Stud*
“OR” in between each term

Four major databases were searched. These four were selected as they were of relevance to the topic and were deemed to be
large enough to encompass the majority of literature on the topic. The search yielded 4183 abstracts.
In each database, citations were retained if the title clearly met the following three criteria (criteria 1):
1. Indicated that the study included subjects with COPD
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3.

3

Studies reported on change in respiratory impairment, with a follow-up period of 2 years or more.
Title did not contain enough information to discern whether or not points 1 and 2 were present.

Four hundred and fifty seven (457) abstracts for citations which met the initial three criteria were retrieved (if possible), and a
second set of criteria (criteria 2) was then applied. Studies which did not meet more than one of the criteria were excluded on the
basis of the first criterion point they did not meet. Citations were retained if:
1.
2.
3.
4.

Studies included subjects with a diagnosis of COPD at the initial collection of data, as defined by a forced expiratory
volume in one second less than 70% of predicted value (FEV1% predicted <70) [61 citations excluded]
Studies contained data collected at least 2 years apart [21 citations excluded]
Studies included primary outcome measures of quality (descriptions, words, unpleasantness rating), intensity (eg. VAS,
Borg) and/ or respiratory related impairments (perceived respiratory related impairment (eg. Medical Research Council
dyspnoea scale) or respiratory related quality of life (eg. St George Respiratory Questionnaire) [130 citations excluded]
Title/abstract of the article did not contain enough information to discern whether or not points 1, 2 and 3 were present

Two hundred and forty four (244) full text versions of each citation meeting the second inclusion criteria were retrieved and a
third and final set of criteria were applied (criteria 3):
1.
2.
3.
4.
5.

Studies included subjects with a diagnosis of COPD at the initial collection of data (clinically verified: mean FEV1%
predicted <70) [36 citations excluded]
Studies reported changes over a period of 2 or more years [59 citations excluded]
Studies included primary outcome measures of quality (descriptions, words), intensity (eg. Visual analogue scales, Borg’s
rate of perceived exertion scale), respiratory related impairments (eg. Medical Research Council scale for
breathlessness), and/or quality of life (eg. St George Respiratory Questionnaire) [64 citations excluded]
Any interventional methods used within studies were non-surgical in nature (ie. exclude lung volume reduction/ transplant
surgery etc) [21citations excluded]
Studies contain primary data on the sensation of breathlessness (quality or intensity) (ie. no narrative reviews) [49
citations excluded]
Table 2: Results of the systematic search.

Database
PubMed
CINAHL
Academic Search
Elite
Scopus

Limits
Language (English)
Nil

Number of articles
3351
455

Retained (criteria 1)
337
56

Retained (criteria 2)
180
29

Retained (criteria 3)
13
1

Nil

123

17

8

1

Language (English);
Type (Articles and
Reviews)

254

47

27

0

RESULTS
From the 4183 abstracts initially obtained from the systematic search of the four databases, 12 articles were included for full
analysis after removal of duplicates between databases. All studies were published between 1995 and 2007. While the search
strategy included studies which reported longitudinal data for two or more years, for consistency of analysis and reporting data
between studies, only data for a two year period were extracted regardless of whether studies collected data over a longer time
period. Five of the studies were observational, while the remaining 7 studies were interventional. The Lewis Olds Williams (LOW)
critical appraisal tool was used to appraise the interventional studies for potential methodological bias. 10 Each item in the LOW
tool has three possible answers: “Yes”, “No” and “Can’t Tell”, with the first response designating a score of 1, and the latter two a
score of 0. The Critical Appraisal Skills Programme 2004 (CASP) instrument for cohort studies was used to assess the
observational studies for methodological bias. This instrument consists of 12 questions, with ten of these allowing a “Yes”, “No”
or “Can’t tell” response.
Appraisal of the 12 articles revealed that results from the studies appeared believable with the majority of studies have few
issues with potential bias (average score 7/9). Table 3 presents the results of the critical appraisal of each study according to the
specific scoring criteria.
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TABLE 3: Critical appraisal of studies
Study Type
Interventional studies

√

√

Focused issue

Acceptable recruitment

X

√

√

√

√

√

√

Appropriate method

Oga et al 2007 21

Naunheim et al 200616

√

Cote, Dordelly and Celli
2007 20

Cote and Celli 200515

√

Mahler et al 1995 19

Ries et al 2003 1

√

Hesselink et al 2006 18

Spencer et al 2001 13

√

Modified checklist:
The Critical Appraisal
Skills Programme 2004
(CASP)

Observational studies

√

√

√

√

√

√

√

√

√

√

Miravitlles et al 2004 17

Guell et al 2000 12

√

Clini et al 2002 14

van Schayck et al 1995 11

Focused issue

LOW critical appraisal point

4

Sufficient number

?

√

?

√

?

?

?

Acceptable recruitment
√

√

√

√

√

Control group

√

√

√

√

√

√

X

√

√

√

√

√

Subjects managed
acceptably

√

√

?

√

√

X

√

Exposure accurately
measured
Outcome accurately
measured

√

√

√

√

√

Unbiased outcome
measures

√

√

√

√

√

?

√

Confounded factors
accounted for

√

√

?

√

√

Confounding factors
accounted for

√

√

√

√

√

√

X

Adequate follow up of
subjects

√

√

√

√

√

Effect size calculated

√

√

√

√

√

√

√

Precise results

√

√

?

?

?

Acceptable results

√

√

√

√

√

√

√

Acceptable results

√

√

√

√

√

Applicable to general
population

√

√

?

√

√

Results fit with other
evidence

√

√

√

√

√

KEY: LOW= Lewis Olds Williams; √= Yes; X= No; ?= Can’t tell
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TABLE 4: Interventional methods used in the studies
Interventional method
Nil
Surgery (eg.
lung volume
reduction)
Study
van Schayck et al 1995
Mahler et al 1995
Guell et al 2000
Spencer et al 2001
Clini et al 2002
Ries et al 2003
Miravitlles et al 2004
Cote and Celli 2005
Hesselink et al 2006
Naunheim et al 2006
Cote, Dordelly and Celli 2007
Oga et al 2007

Non-invasive
positive
pressure
ventilation

Pulmonary
rehabilitation

Long
term
oxygen
therapy

Drug

Placebo

Other

The interventional methods used within the studies are reported in Table 4. Whilst the methods of intervention may have an
impact on the results obtained through the various outcome measures, many of the treatments used within the studies are
currently considered “usual care” for COPD, and subjects involved in the observational studies may have been under similar
management. The decision to exclude studies in which surgery was the form of intervention was decided on as the impact of
surgery on outcome measures is frequently dramatic and not representative of the normal progression of COPD. In the study by
Naunheim et al (2006), surgical intervention was trialled against a more “usual” form of management. Only the data of the latter
group was extracted and analysed.16
Subjects
The Global Initiative for Chronic Lung Disease (GOLD) stages classification of COPD is as follows: 22
All have a forced expiratory volume in one second1 to forced vital capacity ratio (FEV/FVC) < 0.70, plus
Ø Stage 1 (Mild): FEV1 ≥ 80% predicted
Ø Stage 2 (Moderate): 50% ≤ FEV1 < 80% predicted
Ø Stage 3 (Severe): 30% ≤ FEV1 < 50% predicted
Ø Stage 4 (Very Severe): FEV1 < 30% predicted or FEV1 < 50% predicted plus chronic respiratory failure
Table 5 presents the mean baseline FEV1% predicted for the 12 studies within the review, the subsequent classification of
subjects according to the GOLD criteria, and the changes in airways obstruction reported over each 2 year period. Two studies
did not report airways obstruction as a percentage of the predicted value, but rather as a volume (litres).1,20 Taking average
values for FEV1% predicted, this places the majority of subjects within the 12 studies in the “severe” category at commencement
of the 2 year time frame.
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TABLE 5: Classification of subjects within studies according to the GOLD classification
Study
van Schayck et al 1995
Mahler et al 1995
Guell et al 2000
Spencer et al 2001
Clini et al 2002
Ries et al 2003
Miravitlles et al 2004
Cote and Celli 2005
Hesselink et al 2006
Cote, Dordelly and Celli 2007
Naunheim et al 2006
Oga et al 2007

Baseline FEV1% predicted (unless otherwise
indicated)
70 ± 16 (moderate)
1.28 ± 0.59 litres
31 ± 12 (PR group) (severe)
39 ± 14 (nil intervention group) (severe)
50 ± 15 (moderate)
28 ± 11 (NPPV group) (very severe)
31 ± 11 (LTOT group) (severe)
1.07 ± 0.43 litres (PR maintenance)
1.14 ± 0.42 litres (control)
33 ± 8 (severe)
33 ± 9 (Pulmonary Rehab group) (severe)
30 ± 9 (no intervention group) (very severe)
61 ± 16 (moderate)
40 ± 15 (exaerbators) (severe)
49 ± 16 (non-exacerbators) (severe)
27 ± 7 (very severe)
46 ± 1.3 (severe)

Mean change in FEV1 over 2 years
1.46L decrease
0.07L increase
1% increase (PR group)
2.5% decrease (nil intervention group)
Not reported
0.5% increase (NPPV)
0.2% decrease (LTOT)
0.06L decrease (PR maintenance)
0.07L decrease (control)
“no significant difference”
0.02L decrease (PR group)
0.16L decrease (no intervention group)
3.17% decrease
6.6% decrease (exacerbators)
3.6% decrease (non-exacerbators)
Not reported
1.8% decrease

KEY: NPPV= non-invasive positive pressure ventilation; LTOT= long term oxygen therapy; PR= pulmonary rehabilitation
Changes in Impairment
Across all of the studies within the review, changes in FEV1% predicted or an equivalent marker were minor (a mean 2%
decrease over two years). The majority of studies, including interventional studies, reported minor deteriorations in airway
obstruction over a two year period, as measured by FEV1 in litres or FEV1% predicted. However, these changes were often very
small, and not statistically significant. As a result of this analysis, the results have been reported across all studies rather than
separately for intervention and observational studies. The most dramatic change observed was that of the group people prone to
multiple repeated infections or exacerbations of their lung disease (“exacerbators”) within the 2007 study by Cote and
colleagues, presenting a 7% decrease in the predicted value (FEV1% predicted) over a two year period.20
Outcome Measures Used to Monitor Changes in the Sensation of Dyspnoea
Thirteen different measures were used by the 12 studies to assess and monitor changes in the sensation of breathlessness or
related-impairments. Several studies used multiple tools, resulting in a total of 25 outcome measures for subjects across the
studies. Table 6 gives a brief description of each of the tools used to assess changes (improvement or deterioration) in
breathlessness over a two year period. Table 7 presents the measures used within each study and the changes observed over
the two year period.
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TABLE 6: Description of tools used to measure breathlessness
Domain of
measurement

Perceived intensity
of breathlessness

Perceived severity of
breathlessness

Perceived severity of
respiratory-related
impairment

Generic quality of life

Tool

Description

Borg Perceived Rate of
Exertion scale
Visual Analogue Scale
(VAS)
University of California,
San Diego Shortness of
Breath Questionnaire
(UCSD SOBQ)
Baseline Dyspnea
Index/ Transitional
Dyspnea Index
(BDI/ TDI)

A 0 to 10 scale with some numbers accompanied by descriptions of perceived rate of
exertion. A higher score indicates a worse perception of rate of exertion.
10cm line, only markers being 0 (no problems) and 10 (worst). Number of cm from zero
marked as score. A higher score indicates a worse degree of dyspnoea.
24 activities listed. Rate each from 0 (not breathless at all) to 5 (maximally breathless).
Overall score of between 0 and 120 produced. A higher score indicates a worse degree of
dyspnoea.

(Modified) Medical
Research Council scale
for dyspnoea (MRC/
MMRC)
Quality of life for
respiratory illness
questionnaire
(QOL-RIQ)
Short Form 36 Health
Survey (SF-36)
Chronic Respiratory
Questionnaire (CRQ)
Inventory of Subjective
Health (ISH)
Quality of Well Being
(QWB)
Rand 36-Item Health
Survey

Respiratory related
quality of life

Maugeri Foundation
Respiratory Failure
Questionnaire
(MRF-28)
Saint George
Respiratory
Questionnaire (SGRQ)

The BDI rates dyspnoea in three categories: functional impairment, magnitude of task,
magnitude of effort. Each is graded (0 to 4), scores are added together to produce overall
score between 0 and 12. A higher score indicates a worse degree of dyspnoea. The TDI
rates changes in each of the three categories, grading each (-3 to +3) to produce an
overall transition score between –9 and + 9.
MRC is 1 to 5 scale with descriptions corresponding with each grade. MMRC is same set
of descriptions, but scale is instead 0-4. Subject asked to pick description that best applies
to them. A higher score indicates a worse degree of dyspnoea.
55 questions on seven subscales. For each item on 7-point Likert scale, subjects
nominate degree to which they are troubled due to pulmonary complaints, resulting in an
overall score between 7 and 49. A higher score indicates worse quality of life.
36 item multiple choice questionnaire; produces scores in eight domains; overall score of
0 to 100 is produced. A lower score indicates worse health-related quality of life.
20 questions in four areas: dyspnea (5 questions), fatigue (4 questions), emotional
functioning (7 questions), and mastery (4 questions). Subjects rate each domain on a 7point scale ranging from 1 (maximum impairment) to 7 (no impairment). A lower score
indicates worse health-related quality of life.
21 item questionnaire with questions relating to several areas, including tiredness, heart
and chest problems, gastric problems, and headache. A total score of between 0 and 21 is
produced. A higher score indicates worse health-related quality of life.
A 4 item interviewer-administered questionnaire with questions in four areas:
Symptom/complex, mobility, physical activity, and social activity. An overall score between
0 and 1 is produced. A lower score indicates worse health-related quality of life.
Similar to the SF-36. Includes 36 questions in eight domains, with the addition of a
question regarding change in health. An overall score of between 5 and 40 is produced. A
higher score indicates worse health-related quality of life.
21 item, self-administered questionnaire, with items in 3 domains: daily activity, cognitive
function and invalidity. Produces an overall score of 0 to 100. A higher score indicates
worse health-related quality of life.
76 item multiple choice questionnaire; produces scores in three domains; an overall score
of 0 to 100 is produced. A higher score indicates worse health-related quality of life.
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TABLE 7: Measures used to track changes in breathlessness over 2 years (changes reported in individual scale of each
measure)

Oga et al 2007

Cote, Dordelly and
Celli 2007

Naunheim et al 2006

Hesselink et al 2006

Cote and Celli 2005

Miravitlles et al 2004

Ries et al 2003

Clini et al 2002

Spencer et al 2001

Guell et al 2000

Mahler et al 1995

van Schayck et al
1995

Tool
Borg

0.5↓*
0.6↓^
4.1↓*
0.5↓^

VAS
USCD
SOBQ
BDI/ TDI

7.3↑*
10.6↑^
0.2↑*
0.1↓^

0.7↓
1.8 ↓*
no change^

MRC/
MMRC
QOLRIQ
SF-36

0.9↓*
0.1↑^

0.14↓*
0.38↑^

0.33↑E
0.12↓non-E

0.28↑

0.89↓
Physical
1.72 ↓*
2.62 ↓^
Mental
1.32 ↓*
2.28 ↓^

CRQ

ISH

6.4↓*
11.4↓^

Dyspnoea
domain
1 ↑*
no change^

0.24↓

1.2↑

QWB

0.12↓*
0.11 ↓^
Physical
4.5↓*
3↓^

Rand

Mental
0.4↓*
2↓^
MRF-28
SGRQ

no
change*
1.4↑^

4↓*
6↓^
4↓*
5↓^

3.79↓

4↑

7 ↑E
1 ↑non-E

KEY: Borg= Borg Perceived Rate of Exertion scale; VAS=Visual Analogue Scale; USCD SOBQ= University of California, San
Diego Shortness of Breath Questionnaire; BDI/TDI= Baseline Dyspnea Index/ Transitional Dyspnea Index; MRC/MMRC=
Medical Research Council scale for dyspnoea/ Modified Medical Research Council scale for dyspnoea; QOL-RIQ= Quality of life
for respiratory illness questionnaire; SF-36= Short Form 36 Health Survey; CRQ= Chronic Respiratory Questionnaire; ISH=
Inventory of Subjective Health; QWB= Quality of Well Being; Rand= Rand 36-Item Health Survey; MRF-28= Maugeri Foundation
Respiratory Failure Questionnaire; SGRQ= Saint George Respiratory Questionnaire; shaded cells= interventional study; bold
font= improvement; ↑= increase in value; ↓= decrease in value; *= interventional group; ^= control / placebo group; E=
exacerbators; Non-E= non exacerbators.
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DISCUSSION
Individual studies have previously assessed longitudinal changes in various domains for people with COPD.1-3 Despite this, a
systematic review focusing specifically on changes in dyspnoea or breathlessness could not be identified. The aim of this review
was to summarise evidence concerning the variety of outcome measures and changes in intensity, quality, or life impact of
dyspnoea for people with COPD over a two year period.
COPD Severity and Changes over Time in Pulmonary Function
Within the 12 studies included in this review, there was little change with respect to disease progression. Where extractable, the
change in FEV1% predicted, as a measure of airways obstruction, was noted. In most of the studies, there was an average mean
decrease in FEV1, but the change was often negligible.
One factor that may have influenced this finding is that most of the subjects within the reviewed studies fell within the “severe”
grouping, according to the GOLD classification. It must be remembered that these people represent the surviving subgroup of
the COPD population. Many others with a similar or greater degree of physiological impairment would have died. It may be that
these subjects had already reached a plateau in terms of disease progression and potentially adapted to this level of disease,
and that if subjects with a lesser initial level of impairment were followed, the changes observed over a two year period may have
been more dramatic. The fact that only studies which reported changes over an exact two year period (regardless of whether
data for longer durations of study were available) were included will also have influenced the results with regard to changes in
impairment. The small changes in airways obstruction may be indicative of the fact that two years is not a long enough period of
time to observe significant changes in the level of impairment in people with COPD unless there are frequent exacerbations of
the disease.
Outcome Measures Used to Monitor Changes in the Sensation of Dyspnoea
Overall, results concerning changes in the sensation of dyspnoea (intensity, severity or quality), its related impairments, and
quality of life for people experiencing it were inconclusive. The measures used to track changes over 2 years can be grouped
into three main categories, and will be discussed in terms of the most commonly used outcome measures for each category. It
must be kept in mind that in most cases, the statistical significance of the changes in the outcome measures within individual
studies was not reported.
Measures of Intensity
Three main measures were used to track changes in the intensity of breathlessness: the VAS, the Borg, and the UCSD SOBQ.
Each of these were used only once across the 12 studies. The VAS was used by Guell and colleagues (2000) in an
interventional study.12 These authors reported small improvements in the intensity of dyspnoea experienced by subjects in both
the intervention (pulmonary rehabilitation) and the control group. These gains were significantly more for the pulmonary
rehabilitation group, and accompanied by a small decrease in airways obstruction. Similarly, using the Borg scale, Ries and
colleagues (2003) noted small but not significant improvements in intensity for both intervention (pulmonary rehabilitation follow
up) and control groups.1 Conversely, the UCSD SOBQ, also used by Ries et al, noted a non-significant increase in the intensity
of breathlessness. This UCSD SOBQ requires subjects to rate intensity across a number of tasks. It may be that the more
multidimensional nature of this tool is a more accurate representation of the dyspnoeic experience than a unidimensional tool
such as the VAS or Borg. In summary, it appears that people with severe COPD who undertake pulmonary rehabilitation report
less intense breathlessness over a two year period, while people with severe COPD who do not undertake pulmonary
rehabilitation report more intense breathlessness over a two year period.
Measures of Respiratory-Related Impairment
A form of the Medical Research Council scale for dyspnoea (either the original or modified version) was also a common tool
throughout five studies. 12, 14, 15, 20-21 The (M)MRC scale requires subjects to rate the degree to which dyspnoea impacts on daily
life. The tool was used with nine groupings of subjects, and four of these demonstrated improvements over the two year period
(and one no change) using a version of the MRC scale. Three of the four groups in which improvement was noted were
recipients of an intervention of some kind. Yet, only one mean improvement was more than a whole grade on the (M)MRC scale.
This suggests that minor improvements in self-reported respiratory-related impairment can be seen over two years for people
with COPD who receive some form of management. For people who receive no treatment, respiratory-related impairment seems
to remain unchanged or slightly worsen.
Measures of Quality of Life
The SGRQ was used in six of the studies, on nine groups of subjects in total. 13, 14, 16, 17, 20 In three of the nine groups of subjects
assessed within these studies, improvement was observed over the two year period. In five groups, health-related quality of life
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deteriorated. One group had no change over the two year period. The greatest change observed was a 7-point increase
(deterioration) in the “exacerbators” group within Cote, Dordelly and Celli’s 2007 study.20 According to Jones and colleagues
(1991), this reflects a moderate change and therefore deterioration in the quality of life for subjects. 23 All other changes in SGRQ
scores across the studies are considered to be of less significance. This demonstrates that overall, no clear conclusions could be
drawn about changes in the effect of dyspnoea on quality of life over two years using the SGRQ.
In this review, both interventional and observational study designs were included. While studies with only surgical interventions
were excluded, and only “usual care” forms of intervention accepted, the interventional methods may have influenced the rate of
change in both airways obstruction, and more importantly, the sensation of dyspnoea. Contrary to what may have been expected
for people with this progressive terminal disease, a large number of studies reported minor improvements in the sensation of
dyspnoea over a two year period. Forty six outcome measurements were reported across the 12 studies (due to the use of
multiple tools and subject groups within each study). Sixteen of these displayed improvement, despite minimal change in
physiological impairment (FEV1). The majority of improvements were noted in interventional studies. This suggests that the
interventions were having an effect on the sensation of breathlessness. However, it may also be a reflection on the coping
mechanisms employed by people with chronic breathlessness. Perhaps improvements in the face of deteriorating or unchanging
physical condition reflect habituation of the individual to their physiological state. It may be that the intensity of breathlessness or
the impact of the sensation on daily activities and quality of life was seen to improve because subjects learned not to put
themselves in breathlessness-provoking situations.
There are a number of clinical implications arising from this review. Breathlessness is one of the most common and disabling
symptoms of COPD. While a substantial body of high level research confirms the benefits of pharmacological approaches and
pulmonary rehabilitation for people with COPD, in the real world environment, it is not uncommon to find health professionals
offering optimal pharmacological management to people with severe airflow obstruction but expressing concern or reticence in
referring people to pulmonary rehabilitation programmes. The majority of studies in this review included people with severe
airflow obstruction (FEV1 30 to 50% predicted) and the findings indicated that, unless people suffer frequent respiratory
exacerbations, access to “usual care” (optimal pharmacological management and pulmonary rehabilitation) is likely to result in, at
worst, little deterioration and at best, small improvements in the sensation (intensity and impact) of breathlessness over a two
year period. For people with COPD and health professionals working with people with COPD, these findings should encourage
referral and participation in both aspects of “usual care.” The variety of outcome measures used to assess and monitor
breathlessness make it difficult to descriptively compare between studies and make statistical processes, such as meta-analysis,
impractical. In addition, the findings from recent neural images studies indicate that two discretely different domains exist for the
sensation of breathlessness; affective (unpleasantness) and sensory (intensity).4 To date, outcome measures used to capture
the experience of breathlessness attend to intensity and the behaviour impacts of breathlessness, rather than the affective or
qualitative sensation. Clinicians and researchers intending to assess the sensation of breathlessness should consider using tools
which assess both of these domains through either simple visual analogue scales for intensity and unpleasantness or more
comprehensively through structured interviews for the language of breathlessness.5-7, 24
CONCLUSION
The aim of this systematic review was to identify which assessment tools have been used to monitor the sensation of
breathlessness and whether the sensation of breathlessness changed over two years in people with COPD. The studies included
within this review reported on three broad groups of outcome measures: intensity, respiratory-related impairment, and quality of
life. As neural images studies have only been published in the past year indicating that breathlessness has two discrete neural
pathways for intensity and unpleasantness, it was not surprising that no longitudinal studies included within this review
specifically assessed the qualitative sensation of unpleasantness.
In terms of changes across a two year period, this systematic review found that for people with predominantly severe airflow
obstruction and physiological impairment, as measured by FEV1, did not change significantly over a two year period. Similarly,
little to no change was observed in the intensity of breathlessness, its impact on activities of daily living and on general quality of
life.
The findings suggest that the sensation of breathlessness does not change significantly over a two year period for people with
severe COPD. Many of the studies included in this review trialled a variety of interventions with subject groups, and as such, the
findings in regards to change in impairment levels and the sensation of breathlessness may be partly attributable to the
interventional methods, many of which are considered best practice or usual care for this group (optimal pharmacological
management and pulmonary rehabilitation). Most outcome measurement tools employed within the studies were unidimensional
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in nature, or measured the effects of the sensation on activities of daily living or quality of life. As such, little is known about
whether or how the qualitative sensation of breathlessness changes over time in people with chronic pulmonary disease.
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